SCCM Resource Library-2024 Focused Update Guidelines on Use of Corticosteroids in Sepsis, Acute Respiratory Distress Syndrome, and Community-Acquired Pneumonia

2024 Focused Update Guidelines on Use of Corticosteroids in Sepsis, Acute Respiratory Distress Syndrome, and Community-Acquired Pneumonia

Back to course

Video Transcription

Video Summary

Dipayan Chaudhary presented an update from McMaster University on 2024 guidelines for corticosteroid use in sepsis, ARDS, and community-acquired pneumonia. Initially, a 2008 consensus tackled corticosteroid insufficiency in critical illness, updated in 2017 with rigorous guidelines. The 2024 update addresses new data from trials, focusing specifically on corticosteroid use in common diagnoses. A 22-member panel with varied expertise crafted five PICO questions to guide their recommendations. A systematic review and meta-analysis were performed, integrating patient and provider values, costs, and evidence quality. This comprehensive approach informed the resulting guidelines for corticosteroid usage.

Asset Caption

One-Hour Concurrent Session | New SCCM Guidelines: Liver Failure, New Fever, and Corticosteroids

Meta Tag

Content Type Presentation

Membership Level Professional

Membership Level Select

Year 2024

Keywords

corticosteroid guidelines

sepsis

ARDS

community-acquired pneumonia

systematic review

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.